358 related articles for article (PubMed ID: 15217520)
21. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.
Wahlberg SS; Schmeits J; Thomas G; Loda M; Garber J; Syngal S; Kolodner RD; Fox E
Cancer Res; 2002 Jun; 62(12):3485-92. PubMed ID: 12067992
[TBL] [Abstract][Full Text] [Related]
22. Identification of six novel MSH2 and MLH1 germline mutations in HNPCC.
Krüger S; Plaschke J; Jeske B; Görgens H; Pistorius SR; Bier A; Kreuz FR; Theissig F; Aust DE; Saeger HD; Schackert HK
Hum Mutat; 2003 Apr; 21(4):445-6. PubMed ID: 12655562
[TBL] [Abstract][Full Text] [Related]
23. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
Alazzouzi H; Domingo E; González S; Blanco I; Armengol M; Espín E; Plaja A; Schwartz S; Capella G; Schwartz S
Hum Mol Genet; 2005 Jan; 14(2):235-9. PubMed ID: 15563510
[TBL] [Abstract][Full Text] [Related]
24. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.
Berends MJ; Wu Y; Sijmons RH; Mensink RG; van der Sluis T; Hordijk-Hos JM; de Vries EG; Hollema H; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
Am J Hum Genet; 2002 Jan; 70(1):26-37. PubMed ID: 11709755
[TBL] [Abstract][Full Text] [Related]
25. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
[TBL] [Abstract][Full Text] [Related]
26. Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia.
Bartosova Z; Fridrichova I; Bujalkova M; Wolf B; Ilencikova D; Krizan P; Hlavcak P; Palaj J; Lukac L; Lukacova M; Böör A; Haider R; Jiricny J; Nyström-Lahti M; Marra G
Hum Mutat; 2003 Apr; 21(4):449. PubMed ID: 12655568
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).
Loukola A; Eklin K; Laiho P; Salovaara R; Kristo P; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
Cancer Res; 2001 Jun; 61(11):4545-9. PubMed ID: 11389088
[TBL] [Abstract][Full Text] [Related]
28. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
[TBL] [Abstract][Full Text] [Related]
29. Hereditary nonpolyposis colorectal cancer in endometrial cancer patients.
Yoon SN; Ku JL; Shin YK; Kim KH; Choi JS; Jang EJ; Park HC; Kim DW; Kim MA; Kim WH; Lee TS; Kim JW; Park NH; Song YS; Kang SB; Lee HP; Jeong SY; Park JG
Int J Cancer; 2008 Mar; 122(5):1077-81. PubMed ID: 17973265
[TBL] [Abstract][Full Text] [Related]
30. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
[TBL] [Abstract][Full Text] [Related]
31. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
[TBL] [Abstract][Full Text] [Related]
32. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
[TBL] [Abstract][Full Text] [Related]
33. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
[TBL] [Abstract][Full Text] [Related]
34. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
35. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families.
Shin YK; Heo SC; Shin JH; Hong SH; Ku JL; Yoo BC; Kim IJ; Park JG
Hum Mutat; 2004 Oct; 24(4):351. PubMed ID: 15365995
[TBL] [Abstract][Full Text] [Related]
37. Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer.
Caluseriu O; Cordisco EL; Viel A; Majore S; Nascimbeni R; Pucciarelli S; Genuardi M
Hum Mutat; 2001 Jun; 17(6):521. PubMed ID: 11385712
[TBL] [Abstract][Full Text] [Related]
38. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
39. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]